Min Yan
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 25
- MicroRNA in disease regulation 24
- Oncology 97
- HER2/EGFR in Cancer Research 31
- Cancer Treatment and Pharmacology 21
- Co-authors
- bingya Liu (62 shared papers)Zhenggang Zhu (59 shared papers)Liping Su (35 shared papers)Jianfang Li (31 shared papers)Beiqin Yu (21 shared papers)Gaoming Liao (13 shared papers)Liwen Xu (11 shared papers)Yun Xiao (12 shared papers)
- Journals
- Oncotarget (12 papers)Frontiers in Oncology (11 papers)Nature Communications (9 papers)BMC Cancer (7 papers)PLoS ONE (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Min Yan
388 papers receiving 14.8k citations
Min Yan's Hit Papers
Peers
Comparison fields: 5 of 167
- Cancer Research 3.6k
- Oncology 3.6k
- Pulmonary and Respiratory Medicine 2.7k
- Molecular Biology 6.1k
- Cell Biology 1.0k
Countries citing papers authored by Min Yan
This map shows the geographic impact of Min Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Yan more than expected).
Fields of papers citing papers by Min Yan
This network shows the impact of papers produced by Min Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Yan. The network helps show where Min Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 411 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CellMarker: a manually curated resource of cell markers in human and mouse Hit paper breakdown → | 2018 | 1015 |
| 2 | CancerSEA: a cancer single-cell state atlas Hit paper breakdown → | 2018 | 687 |
| 3 | Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer Hit paper breakdown → | 2021 | 581 |
| 4 | TIP: A Web Server for Resolving Tumor Immunophenotype Profiling Hit paper breakdown → | 2018 | 508 |
| 5 | 2014 | 451 | |
| 6 | HER2 expression status in diverse cancers: review of results from 37,992 patients Hit paper breakdown → | 2015 | 403 |
| 7 | Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial Hit paper breakdown → | 2021 | 318 |
| 8 | 2017 | 291 | |
| 9 | 2012 | 256 | |
| 10 | 2010 | 245 | |
| 11 | 2016 | 237 | |
| 12 | 2014 | 227 | |
| 13 | 2019 | 197 | |
| 14 | 2019 | 197 | |
| 15 | 2014 | 184 | |
| 16 | 2015 | 175 | |
| 17 | 2012 | 167 | |
| 18 | 2016 | 157 | |
| 19 | 2014 | 135 | |
| 20 | 2016 | 126 |
About Min Yan
Min Yan is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Cell Biology, having authored 411 papers that have together received 15.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (45 papers), HER2/EGFR in Cancer Research (31 papers), Advanced Breast Cancer Therapies (27 papers), Cancer-related molecular mechanisms research (25 papers), MicroRNA in disease regulation (24 papers), Cancer Treatment and Pharmacology (21 papers), Microtubule and mitosis dynamics (21 papers) and RNA modifications and cancer (17 papers). The work is most often cited by research in Cancer Research (3.6k citations), Oncology (3.6k citations), Pulmonary and Respiratory Medicine (2.7k citations), Molecular Biology (6.1k citations) and Cell Biology (1.0k citations). Min Yan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include bingya Liu, Zhenggang Zhu, Liping Su, Jianfang Li, Beiqin Yu, Gaoming Liao, Liwen Xu, Yun Xiao, Xia Li and Chunyu Deng. Their work appears in journals such as Oncotarget, Frontiers in Oncology, Nature Communications, BMC Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.